CureVac NV (CVAC)
3.67
-0.33
(-8.25%)
USD |
NASDAQ |
Jun 14, 16:00
3.675
0.00 (0.00%)
After-Hours: 20:00
CureVac Enterprise Value: 494.96M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 494.96M |
| June 13, 2024 | 568.98M |
| June 12, 2024 | 602.63M |
| June 11, 2024 | 625.06M |
| June 10, 2024 | 701.32M |
| June 07, 2024 | 678.89M |
| June 06, 2024 | 791.04M |
| June 05, 2024 | 687.86M |
| June 04, 2024 | 577.95M |
| June 03, 2024 | 645.25M |
| May 31, 2024 | 544.31M |
| May 30, 2024 | 517.39M |
| May 29, 2024 | 521.88M |
| May 28, 2024 | 494.96M |
| May 24, 2024 | 499.45M |
| May 23, 2024 | 562.25M |
| May 22, 2024 | 548.79M |
| May 21, 2024 | 409.72M |
| May 20, 2024 | 434.40M |
| May 17, 2024 | 454.59M |
| May 16, 2024 | 452.34M |
| May 15, 2024 | 387.29M |
| May 14, 2024 | 367.11M |
| May 13, 2024 | 337.95M |
| May 10, 2024 | 324.49M |
| Date | Value |
|---|---|
| May 09, 2024 | 340.19M |
| May 08, 2024 | 317.76M |
| May 07, 2024 | 342.43M |
| May 06, 2024 | 332.34M |
| May 03, 2024 | 373.84M |
| May 02, 2024 | 293.09M |
| May 01, 2024 | 266.17M |
| April 30, 2024 | 237.01M |
| April 29, 2024 | 237.01M |
| April 26, 2024 | 194.39M |
| April 25, 2024 | 189.91M |
| April 24, 2024 | 234.77M |
| April 23, 2024 | 254.95M |
| April 22, 2024 | 239.25M |
| April 19, 2024 | 219.06M |
| April 18, 2024 | 219.06M |
| April 17, 2024 | 248.22M |
| April 16, 2024 | 269.53M |
| April 15, 2024 | 266.17M |
| April 12, 2024 | 324.49M |
| April 11, 2024 | 335.70M |
| April 10, 2024 | 333.46M |
| April 09, 2024 | 337.95M |
| April 08, 2024 | 360.38M |
| April 05, 2024 | 358.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
189.91M
Minimum
Apr 25 2024
23.53B
Maximum
Dec 09 2020
5.203B
Average
1.920B
Median
Jun 26 2023
Enterprise Value Benchmarks
| BioNTech SE | 5.527B |
| Affimed NV | 66.46M |
| Moderna Inc | 45.14B |
| InflaRx NV | 1.237M |
| MorphoSys AG | 2.671B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -76.63M |
| Revenue (Quarterly) | 13.44M |
| Total Expenses (Quarterly) | 94.08M |
| EPS Diluted (Quarterly) | -0.3367 |
| Gross Profit Margin (Quarterly) | -236.9% |
| Profit Margin (Quarterly) | -570.2% |
| Earnings Yield | -36.06% |
| Normalized Earnings Yield | -36.33 |